Navigation Links
ANA773 Demonstrates Significant Antiviral Response in Early Clinical Trial in Hepatitis C Patients
Date:8/11/2009

in nature constitute "forward-looking statements." Such statements include, but are not limited to, references to (i) Anadys' belief that ANA773 holds promise as a potential replacement for injectable interferon products in HCV therapy; (ii) Anadys' ability to seek and obtain partnership opportunities to further the development of ANA773; (iii) the ability to create well-tolerated, all oral combination regimens to treat hepatitis C; (iv) the potential to further improve response by combining ANA773 with other agents, including ribavirin; and (v) the potential for alternative dosing schedules to further improve pharmacological response to TLR7 activation. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause Anadys' actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. For example, the results of preclinical and early clinical studies may not be predictive of future results, and Anadys cannot provide any assurances that ANA773 will not have unforeseen safety issues or will have favorable results in future clinical studies. Furthermore, Anadys cannot provide any assurances that it will be able to obtain a partnership around ANA773 or that the development of the program will be continued. In addition, Anadys' results may be affected by risks related to competition from other biotechnology and pharmaceutical companies, its effectiveness at managing its financial resources, its ability to enter into collaborations around its product candidates, its ability to successfully develop and market products, difficulties or delays in its preclinical studies or clinical trials, difficulties or delays in manufacturing its clinical trials materials, the scope and validity of patent protection for its product candidates, regulatory developments involving its product candidates and its ability to obtain additional funding to support
'/>"/>
SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Fruitfly Model of a Neuropathic Disease Demonstrates Novel Role for Proteins in the Family of aTyr Pharmas Product Class
2. Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases
3. Thiarabine Demonstrates a Reduction of Both Inflammatory and Erosive Disease Parameters in Rheumatoid Arthritis
4. Vantia Therapeutics Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia
5. Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R)
6. Study Demonstrates Efficacy of Pitavastatin in Elderly Patients
7. Semafores SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in Phase I Solid Tumor Patients
8. Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results
9. Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen
10. ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients
11. Study Demonstrates Restylane(R) Effect Lasted 18 Months in 97% of Patients With One Repeat Injection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Aug. 31, 2015 With increasing clinical ... experiencing a rise in active partnerships. The primary ... nations to quantitate CD4 cell markers in human ... http://photos.prnewswire.com/prnh/20150831/262206LOGO New analysis ... Flow Cytometry Market ( http://www.frost.com/nf0e ), finds the ...
(Date:8/31/2015)... Pa. , Aug. 31, 2015  The departments ... an event today at Gaudenzia Concept 90 to raise ... drug overdose crisis in Pennsylvania ... treatment and focus on recovery through the Building ... many Pennsylvanians are dying every day to a disease ...
(Date:8/31/2015)...  Diplomat Pharmacy, Inc. (NYSE: DPLO ), the nation,s ... , Chairman & CEO, and Sean Whelan , CFO, ... Mr. Hagerman and Mr. Whelan are scheduled to participate in ... on Wednesday, September 9, 2015 at 1:45 PM ... scheduled to participate in the Robert W. Baird 2015 Healthcare ...
Breaking Medicine Technology:Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 2Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 3Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 4Pennsylvania Departments of Drug & Alcohol Programs and Health Kick-off Second Annual Building Bridges to Recovery Initiative 2Diplomat to Participate in Upcoming Investor Conferences 2
... Blumenthal,Cancer Center at Carolinas Medical Center (CMC) in ... a study that could lead to individualized,treatments for ... hospital system,outside Moffitt,s home state of Florida to ... will enroll more than 2,300 patients in,the study, ...
... of patients remain symptom-free and off daily GERD ... after transoral incisionless ... EndoGastric Solutions, the,world leader in natural orifice surgery ... of 1-year follow-up on GERD patients,in the phase ...
Cached Medicine Technology:CMC, Moffitt Partner to Study Cancer 2EndoGastric Solutions(TM) Announces Results of EsophyX(TM) Multi-Center GERD Study 2EndoGastric Solutions(TM) Announces Results of EsophyX(TM) Multi-Center GERD Study 3EndoGastric Solutions(TM) Announces Results of EsophyX(TM) Multi-Center GERD Study 4
(Date:8/31/2015)... ... August 31, 2015 , ... In preparation for this November’s National Family ... BEAN™ personal sound amplifier, is offering caregivers “7 Reasons to Care about Hearing Health.” ... coping with a variety of home healthcare challenges, specifically as they relate to caring ...
(Date:8/31/2015)... VA (PRWEB) , ... August 31, 2015 , ... For ... its supporters have acknowledged September 26th as Mesothelioma Awareness Day . On this ... interested allies with several ways of becoming involved and helping the cause. , “One ...
(Date:8/31/2015)... ... August 31, 2015 , ... MeYou Health ®, a ... mobile walking app, Walkadoo , by including an in-app step tracker. , ... to each person’s walking habits. Rather than broadly assign every Walkadoo member 10,000 steps ...
(Date:8/31/2015)... ... August 31, 2015 , ... It’s a lot like coming home. Life-long ... of Geneva. During his first days on the job, he’s run into residents of ... and I like knowing that they’re living in such a wonderful place,” he said. ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... Exchange and Organization Supporting Business Owners and provided a tour of their North ... represents the success possible to international companies expanding business in the U.S. ...
Breaking Medicine News(10 mins):Health News:Etymotic Offers Caregivers “7 Reasons to Care about Hearing Health” 2Health News:Etymotic Offers Caregivers “7 Reasons to Care about Hearing Health” 3Health News:Cancer Research Organization Paints the World in Mesothelioma Awareness 2Health News:Cancer Research Organization Paints the World in Mesothelioma Awareness 3Health News:Walkadoo™ Walking Program Now Includes In-app Step Tracker 2Health News:Friendship Senior Options Welcomes New Executive Director for GreenFields of Geneva 2Health News:PartnerTech Supports Economic Growth as Host 2
... What else could you do with,$150,000? That,s the ... and makeup for Gov. Sarah Palin., Contrast ... outfitted in scrubs,for just $10 for a hospital ... scrubs," notes Geri Jenkins, RN, co-president of the ...
... to present at the 2008 Life Sciences and Healthcare Venture Summit October 30, ... ... 2008 -- Curemark announced today that it has been chosen to ... to be held in New York City., , ,The 2008 Life Sciences and ...
... population and increasing concerns for oral hygiene are considered the main factors ... is projected to reach $12.7 billion by the year 2012. , ... ... is one of the most dynamic segments of the oral care market. ...
... 29 The Ensign,Group, Inc. (Nasdaq: ENSG ... of,skilled nursing, rehabilitative care services and assisted living,companies, ... nursing,facilities in Texas and California for an aggregate ... ), Previously leased facilities now owned, ...
... 28 Today the ... responded to a request ... to hold an unnecessary,debate., ... letters, please visit:, http://www.noonprop8.com/downloads/FSchubert102808.pdf ...
... ATSI ), manufacturer and marketer of state-of-the-art ... will release,financial results for the third quarter ended ... November 3, 2008. The Company will host a,conference ... at 5:00 p.m.,Eastern Time (2:00 p.m. Pacific Time) ...
Cached Medicine News:Health News:Nurses Present Palin Clothing Line Website ... and Other Ways the Money Could Have Been Spent 2Health News:Curemark to Present at the 2008 Life Sciences & Healthcare Venture Summit 2008 2Health News:Global Toothpaste Market to Reach $12.7 Billion by 2012, According to a New Report by Global Industry Analysts, Inc. 2Health News:Global Toothpaste Market to Reach $12.7 Billion by 2012, According to a New Report by Global Industry Analysts, Inc. 3Health News:The Ensign Group, Inc. Acquires Four Skilled Nursing Facilities 2Health News:ATS Medical Announces Third Quarter 2008 Earnings Release Date and Conference Call 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: